Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

Merck, known as MSD outside of the United States and Canada, will gain CN201, a next-generation bispecific antibody, from Curon Biopharmaceutical in a deal potentially worth up to $1.3 billion. This ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... Lower interest rates have also eased capital costs, contributing to increased mergers and acquisitions activity.

Merck's move for Sigma-Aldrich is the latest in a series of major merger and acquisition moves in the pharma sector, but creates a new company to serve the global pharma industry, rather than a ...

Merck stock jumped Thursday after the pharma Goliath said it's already on the hunt for acquisitions worth $1 billion to $15 billion to contend with a patent cliff for its bread-and-butter cancer drug.

We recently published a list of Top 10 Best Dividend Stocks on Robinhood. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best dividend stocks ...

While Merck has traditionally relied more on its internal R&D capabilities than mergers and acquisitions to grow its business, new chief executive Robert Davis said earlier this year that approach ...

Merck & Co Inc on Thursday reported steady top-line growth, though profit took a hit due to the cost of recent acquis ... Subscribe now to see this Premium News article from Alliance News ...

President-elect Trump's return to the White House could bring an uptick in mergers and acquisitions, as markets anticipate tax and regulatory reforms that will boost dealmaking. Royal Palm ...